Tailored Approaches to Stroke Health Education (TASHE)
13. juli 2020 oppdatert av: Olajide Williams, Columbia University
The overarching goal of the proposed intervention is to reduce stroke disparities by overcoming pre-hospital barriers related to emergency stroke treatment and facilitating the appropriate response to acute stroke using a novel culturally-tailored and sustainable approach developed by an experienced transdisciplinary team.
Building on our previous work, in which the investigators have identified barriers to increasing stroke literacy and behavioral intent to call 911, the investigators will develop and evaluate the effectiveness of a novel, culturally tailored intervention using storytelling (narrative persuasion) in the form of two professionally produced 12-minute films (in English and Spanish), in minority populations in New York City (NYC).
Behavioral intent to call 911 will be assessed immediately after viewing the film, 6 months later, and one year later.
Studieoversikt
Status
Fullført
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
Stroke is the leading cause of adult disability and costs U.S. taxpayers >$60 billion annually.
Interventions designed to educate patients to seek treatment sooner when a stroke occurs may increase low rates of treatment with thrombolysis (current rates 3% national average).
Thrombolysis can increase the odds of minimal to zero disability from stroke if emergency medical system response times and in-hospital response times are optimized (maximum time from symptom onset to intravenous thrombolysis is 4.5 hours).
Black and Hispanic Americans have higher stroke incidence compared to Whites and are less likely to receive thrombolysis for acute stroke.
The latency to hospital arrival is largely dependent on patients' recognition of stroke symptoms, and immediate presentation to the emergency department.
The investigators have found very low stroke literacy rates among Blacks and Hispanics compared to Whites, which may, in part, be responsible for disparities in acute stroke treatment.
Studietype
Intervensjonell
Registrering (Faktiske)
290
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
New York
-
New York, New York, Forente stater, 10032
- Columbia University Medical Center
-
New York, New York, Forente stater, 10032
- Columbia University Medical Center, Neurological Institute
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
34 år og eldre (Voksen, Eldre voksen)
Tar imot friske frivillige
Nei
Kjønn som er kvalifisert for studier
Alle
Beskrivelse
Inclusion Criteria:
- No prior history of stroke;
- High risk (defined as a history of one or more stroke risk factor (hypertension (HTN), diabetes, tobacco, abdominal obesity, heart disease, high cholesterol);
- Over age 34 years at onset of intervention (we have selected this age cut off due to the large increase in stroke incidence among minority groups at age 34 );
- Self-identified as Black or Hispanic; and
- Member of a church congregation who lives in a household with a telephone.
Exclusion Criteria:
- Participant is unable to give consent;
- A modified Rankin score > 4 at baseline;
- history of dementia; and
- terminal illness, or other medical illness resulting in mortality < 1 year.
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Forebygging
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Intervention Group
Participants will receive education through a novel program called Stroke Education Film Viewing.
|
A novel, culturally tailored intervention using storytelling (narrative persuasion) in the form of two professionally produced 12-min films (in English and Spanish), in minority populations in New York City.
|
|
Annen: Usual Care Group
Participants will receive education through Stroke Education Pamphlet Exposure.
|
"Usual Care": Stroke Education pamphlet and brochure distribution.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Score on Stroke Action Test
Tidsramme: Within one hour of stroke education intervention.
|
The Stroke Action Test (STAT) contains 21 items that name or describe stroke symptoms from all 5 groups of warning signs and 7 items that are nonstroke symptoms.
For each item, the respondent selects 1 of 4 options: call 911, call doctor, wait 1 hour, or wait 1 day.
For scoring purposes, each correct response receives 1 point; incorrect responses receive 0 points.
The total score is reported as percent of correct responses.
Scores range from 0% to 100% with a higher score indicating a better outcome.
|
Within one hour of stroke education intervention.
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Score on Stroke Action Test
Tidsramme: Within six months of stroke education intervention.
|
The Stroke Action Test (STAT) contains 21 items that name or describe stroke symptoms from all 5 groups of warning signs and 7 items that are nonstroke symptoms.
For each item, the respondent selects 1 of 4 options: call 911, call doctor, wait 1 hour, or wait 1 day.
For scoring purposes, each correct response receives 1 point; incorrect responses receive 0 points.
The total score is reported as percent of correct responses.
Scores range from 0% to 100% with a higher score indicating a better outcome.
|
Within six months of stroke education intervention.
|
|
Score on Stroke Action Test
Tidsramme: Within one year of stroke education intervention.
|
The Stroke Action Test (STAT) contains 21 items that name or describe stroke symptoms from all 5 groups of warning signs and 7 items that are nonstroke symptoms.
For each item, the respondent selects 1 of 4 options: call 911, call doctor, wait 1 hour, or wait 1 day.
For scoring purposes, each correct response receives 1 point; incorrect responses receive 0 points.
The total score is reported as percent of correct responses.
Scores range from 0% to 100% with a higher score indicating a better outcome.
|
Within one year of stroke education intervention.
|
Andre resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Time to emergency room after suffering a stroke
Tidsramme: Up to 3.5 years post-intervention
|
This measures the time in getting to the emergency room after having suffered a stroke.
|
Up to 3.5 years post-intervention
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Olajide. A Williams, MD, MS, Columbia University
Publikasjoner og nyttige lenker
Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.
Generelle publikasjoner
- Williams O, Teresi J, Eimicke JP, Abel-Bey A, Hassankhani M, Valdez L, Gomez Chan L, Kong J, Ramirez M, Ravenell J, Ogedegbe G, Noble JM. Effect of Stroke Education Pamphlets vs a 12-Minute Culturally Tailored Stroke Film on Stroke Preparedness Among Black and Hispanic Churchgoers: A Cluster Randomized Clinical Trial. JAMA Neurol. 2019 Oct 1;76(10):1211-1218. doi: 10.1001/jamaneurol.2019.1741.
- Ravenell J, Leighton-Herrmann E, Abel-Bey A, DeSorbo A, Teresi J, Valdez L, Gordillo M, Gerin W, Hecht M, Ramirez M, Noble J, Cohn E, Jean-Louis G, Spruill T, Waddy S, Ogedegbe G, Williams O. Tailored approaches to stroke health education (TASHE): study protocol for a randomized controlled trial. Trials. 2015 Apr 19;16:176. doi: 10.1186/s13063-015-0703-4.
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Faktiske)
16. april 2014
Primær fullføring (Faktiske)
8. juni 2017
Studiet fullført (Faktiske)
1. desember 2019
Datoer for studieregistrering
Først innsendt
22. juli 2013
Først innsendt som oppfylte QC-kriteriene
24. juli 2013
Først lagt ut (Anslag)
26. juli 2013
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
15. juli 2020
Siste oppdatering sendt inn som oppfylte QC-kriteriene
13. juli 2020
Sist bekreftet
1. juli 2020
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- AAAK5853
- 1U54NS081765-01 (U.S. NIH-stipend/kontrakt)
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Nei
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
produkt produsert i og eksportert fra USA
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .